NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

India HIV-CervCa Project

Active Not RecruitingN/A

Sponsor: Abramson Cancer Center at Penn Medicine

Conditions: HIV Positive, HIV Negative, Cervical Cancer

Interventions: Radiation Therapy

Countries: India

The investigators propose to prospectively study the difference in treatment (CTRT) completion and toxicities between HIV positive and HIV negative women in India with locally advanced cervical cancer receiving CTRT.

Eligibility overview

Sex: FEMALE

Age: 18 Years to —

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

* patients with newly biopsy proven squamous carcinoma or adenocarcinoma of the uterine cervix, FIGO stage IB2-IIIB in whom curative CTRT is planned
* Karnofsky performance status ≥ 70
* Patients with lower paraortic lymph nodes (below the level of L2 vertebra)
* patients diagnosed with cervical cancer whom also HIV positive or HIV negative

Exclusion Criteria:

* patients with active tuberculosis

Locations (1)

Mumbai, Maharashtra, India